Advances in Multiple Myeloma From ASH 2020 Advances in Multiple Myeloma From ASH 2020

Breakthroughs in multiple myeloma from ASH 2020 include transplant studies in newly diagnosed patients, triple therapy in early relapse, and CAR T-cell as well as bispecific therapy in later relapse.Medscape

Source: Medscape Today Headlines - December 28, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news